The Australasian Professional Society on Alcohol and other Drugs Conference 2011

Call for Abstracts is now closed.

The 2011 APSAD Conference Scientific Program Committee are calling for abstracts which address all aspects of licit and illicit drug use/misuse.

2011 APSAD Conference Scientific Program Committee required all abstract authors to follow one of the below templates:

Abstract Template A

This will typically suit the structure of empirical studies, but may also be appropriate for qualitative, policy or other types of articles. Authors should note that this format requires the presence of concrete results, and points will be deducted from the assessment of the abstract where these are absent. In the case of research in progress, where results are pending at the time of submission, we would encourage submission using Abstract B. Abstract should be a maximum of 250 words.

Abstract Template B

This will typically suit the structure of reviews, methods papers, qualitative studies, policy analysis or alternative research methods, however, it may also be appropriate for empirical studies. In the case of empirical studies that are in progress, where results are pending at the time of submission, we would encourage submission using Abstract A. Abstract should be a maximum of 250 words.

The Scientific Program Committee may reallocate a presentation type on the basis of time, space available and applicability to the Conference themes.

Abstracts should present original work that has not been published/presented elsewhere.

Abstract submission is a two-step process:

Step 1:

Abstract templates: download one the abstract templates, save it to your desktop and complete it.

To download Abstract Template A, click here (Word, 27KB).

To download Abstract Template B, click here (Word, 27KB)

• Use this template to present your abstract in the required format. Those not submitted using this template will be returned for correction.
• The abstract title should be in initial capital/lower case, not in capitals.
• Authors’ names should be supplied in the surname-last format and should be in initial capital/lower case, not all capitals. Institutional affiliations should be indicated with superscript numbers following the author name.
• All affiliations should contain institution, city and country.
• Each abstract body text should be no more than 250 words and should clearly and concisely summarise the CONTENT of the presentation, identify questions or issues addressed and outline the results or conclusions.
• All information should be presented in a clear and concise manner using headings where possible e.g. Abstract A - Introduction and Aims, Design and Methods, Results, Discussion and Conclusions and for Abstract B – Issues, Approach, Key Findings, Implications and Conclusion.  The abstract should include any relevant data (results or outcomes should be included and will be viewed more favourably).
• Graphics ie graphs, tables, images, etc should be avoided however if included, they must be cited in the abstract text. The abstracts themselves must be in text, not table format. All figures should be cited in the text of the abstract.
• All submissions must be in English.
• Delete all text in red when you have completed this template.

After completing the abstract template, move onto step 2.

Step 2:

Online abstract submission form: to complete the online abstract submission form, the following information is required:

• Your contact details
• The title of your abstract
• Name, affiliation and short biography (100 words) of primary author
• Completed ethical statement on behalf of authors disclosing: Sources of funding – Connection with tobacco, alcohol, pharmaceutical or gaming industry – Constraints on publishing
• Completed funding information
• Agree to the speaker terms and conditions
• Your completed abstract template
• Related theme (please specifiy two from the following):

Please note, the invitation to submit an anstract does not constitute an offer to pay travel, accommodation and/or registration costs associated with the conference. Similarly, no presenter fee is paid to successful participants. All presenters must register for the conference and forward the appropriate registration fee at least six weeks prior to the commencement of the conference.

Please contact Lucy Martin at WALDRONSMITH Management if you have any queries regarding abstract submissions.

E; lucy@wsm.com.au

Ph: 03 9645 6311

Publication of abstracts

Abstracts submitted will be published in a supplement of the Drug and Alcohol Review distributed at the conference. The Drug and Alcohol Review is APSAD’s official journal and is Asia-Pacific’s leading multidisciplinary journal addressing issues related to alcohol and drug-related problems. Published bi-monthly as of 2005, the Drug and Alcohol Review presents original research, policy development and information in the drug and alcohol research field. The journal is an international forum for the views, expertise and experience of all those involved in the study of treatment of alcohol, tobacco and drug problems. The journal represents an important source of information to clinicians, drug and alcohol agency staff, researchers, policy makers, and alcohol service administrators. Please consider this when writing your abstract, structure it accordingly (including any relevant data) and proofread abstracts carefully to avoid errors before submission. Proof pages will be sent to authors in October, it is the author’s responsibility to review proofs and return any corrections by the due date. Change in data or abstract content is not permitted at proof stage. Revisions to abstracts will not be permitted after Tuesday 24 May 2011, submission deadline. For further information please contact the Drug and Alcohol Review editorial officer.

Abstract review notification

Abstract review notification, program scheduling and allocated presentation format will be communicated to the corresponding authors email address from the week commencing June 27. Please note, the details provided as the abstract contact should be for the nominated main contact for your anstract. All correspondence relating to the submission will be directed to this person, and they should in turn distribute to the co-presenters.